Literature DB >> 31918343

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.

F Passiglia1, S Pilotto2, F Facchinetti3, L Bertolaccini4, M Del Re5, R Ferrara6, T Franchina7, U Malapelle8, J Menis9, A Passaro10, S Ramella11, G Rossi12, R Trisolini13, S Novello14.   

Abstract

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical practice guidelines; Metastatic disease; Non-small cell lung cancer; Recommendations

Year:  2019        PMID： 31918343     DOI： 10.1016/j.critrevonc.2019.102858

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


  14 in total

Review 1.  A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done.

Authors:  Lorenzo Belluomini; Alessandra Dodi; Alberto Caldart; Dzenete Kadrija; Marco Sposito; Miriam Casali; Giulia Sartori; Miriam Grazia Ferrara; Alice Avancini; Emilio Bria; Jessica Menis; Michele Milella; Sara Pilotto
Journal:  Transl Lung Cancer Res       Date:  2021-07

2.  Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Giorgia Guaitoli; Marcello Tiseo; Massimo Di Maio; Luc Friboulet; Francesco Facchinetti
Journal:  Transl Lung Cancer Res       Date:  2021-06

Review 3.  Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.

Authors:  Zhe Zhang; Sen Yang; Yanfang Ma; Hanqiong Zhou; Xuan Wu; Jing Han; Jiabao Hou; Lidan Hao; Jonathan D Spicer; Young Wha Koh; Mariano Provencio; Noemi Reguart; Tetsuya Mitsudomi; Qiming Wang
Journal:  Transl Lung Cancer Res       Date:  2021-06

4.  Baseline anemia and anemia grade are independent prognostic factors for stage IV non-small cell lung cancer.

Authors:  Cheng Chen; Zhengbo Song; Wenxian Wang; Juying Zhou
Journal:  Mol Clin Oncol       Date:  2021-01-24

5.  CWHM-1008 Induces Apoptosis and Protective Autophagy through the Akt/mTOR Axis in LUAD Cells.

Authors:  Jiao Zhang; Man-Yuan Li; Xiao Lu; Quan-Xing Liu; Dong Zhou; Gui-Xue Yang; Xiao-Qing Liu; Hong Zheng; Ji-Gang Dai
Journal:  J Oncol       Date:  2021-09-11       Impact factor: 4.375

6.  Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist.

Authors:  Yongjie Yang; Jingli Lu; Yanfang Ma; Chen Xi; Jian Kang; Qiwen Zhang; Xuedong Jia; Kefeng Liu; Shuzhang Du; Florian Kocher; Andreas Seeber; Cesare Gridelli; Mariano Provencio; Nobuhiko Seki; Yusuke Tomita; Xiaojian Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-06

7.  Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation.

Authors:  Rossella Bruno; Marzia Del Re; Federico Cucchiara; Iacopo Petrini; Greta Alì; Stefania Crucitta; Agnese Proietti; Simona Valleggi; Antonio Chella; Romano Danesi; Gabriella Fontanini
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

Review 8.  EGFR exon 20 insertion mutations in non-small cell lung cancer.

Authors:  Fenfang Wang; Chenghui Li; Qihuan Wu; Hongyang Lu
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

Review 9.  An insight into lung cancer: a comprehensive review exploring ALK TKI and mechanisms of resistance.

Authors:  Adela Patcas; Ana Florica Chis; Claudia Florentina Militaru; Ioana Roxana Bordea; Ruxandra Rajnoveanu; Ovidiu Florin Coza; Reem Hanna; Tamas Tiberiu; Doina Adina Todea
Journal:  Bosn J Basic Med Sci       Date:  2022-02-01       Impact factor: 3.363

10.  Observation on the Clinical Effect of Apatinib Combined with Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer.

Authors:  Yu-Jie Cui; Jia Liu; Miao-Miao Liu; Hong-Zhen Zhang
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.